Insider Transactions in Q2 2023 at Denali Therapeutics Inc. (DNLI)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2023
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-0.61%
|
$48,314
$29.76 P/Share
|
|
Jun 16
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-2.18%
|
$1,550,000
$31.4 P/Share
|
|
Jun 16
2023
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
50,000
+2.14%
|
$0
$0.68 P/Share
|
|
Jun 01
2023
|
Jennifer E. Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+21.35%
|
-
|
|
Jun 01
2023
|
Peter S Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+21.35%
|
-
|
|
Jun 01
2023
|
Marc Tessier Lavigne Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+0.22%
|
-
|
|
Jun 01
2023
|
Steve E. Krognes Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+2.78%
|
-
|
|
Jun 01
2023
|
Nancy Thornberry Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+24.9%
|
-
|
|
Jun 01
2023
|
Vicki L Sato Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+3.0%
|
-
|
|
Jun 01
2023
|
Douglas G. Cole Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+13.7%
|
-
|
|
Jun 01
2023
|
Erik Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+27.55%
|
-
|
|
Jun 01
2023
|
Jay T Flatley Director |
BUY
Grant, award, or other acquisition
|
Indirect |
4,216
+1.22%
|
-
|
|
Jun 01
2023
|
David P Schenkein Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+21.35%
|
-
|
|
May 15
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-0.93%
|
$280,000
$28.89 P/Share
|
|
May 15
2023
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+1.82%
|
$50,000
$5.28 P/Share
|
|
Apr 21
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
24,800
-1.1%
|
$620,000
$25.15 P/Share
|
|
Apr 21
2023
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
24,800
+1.08%
|
$0
$0.68 P/Share
|
|
Apr 20
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
200
-0.01%
|
$5,000
$25.0 P/Share
|
|
Apr 20
2023
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
200
+0.01%
|
$0
$0.68 P/Share
|
|
Apr 13
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
4,898
-0.92%
|
$122,450
$25.04 P/Share
|
|
Apr 13
2023
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,898
+0.91%
|
$24,490
$5.28 P/Share
|
|
Apr 12
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
5,102
-0.96%
|
$127,550
$25.04 P/Share
|
|
Apr 12
2023
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Indirect |
5,102
+0.95%
|
$25,510
$5.28 P/Share
|